Subject(s)

COVID-19/blood , Thrombophilia/blood , Thrombosis/blood , Adult , Aged , Antithrombin III/genetics , Antithrombin III Deficiency/blood , Antithrombin III Deficiency/complications , Antithrombin III Deficiency/genetics , COVID-19/complications , COVID-19/physiopathology , Cohort Studies , Factor V Deficiency/blood , Factor V Deficiency/complications , Factor V Deficiency/genetics , Female , Fibrin Fibrinogen Degradation Products , Humans , Hypoprothrombinemias/blood , Hypoprothrombinemias/complications , Hypoprothrombinemias/genetics , Intensive Care Units/statistics & numerical data , Logistic Models , Male , Middle Aged , Mortality , Pilot Projects , Protein C/genetics , Protein C Deficiency/blood , Protein C Deficiency/complications , Protein C Deficiency/genetics , Protein S/genetics , Protein S Deficiency/blood , Protein S Deficiency/complications , Protein S Deficiency/genetics , Respiratory Distress Syndrome/blood , Respiratory Distress Syndrome/physiopathology , SARS-CoV-2 , Severity of Illness Index , Thrombophilia/complications , Thrombophilia/genetics , Thrombophilia/physiopathology , Thrombosis/physiopathology

Subject(s)

COVID-19 Drug Treatment , Chlorpromazine/therapeutic use , Factor V Deficiency/drug therapy , Hemorrhage/drug therapy , Hiccup/drug therapy , Metoclopramide/therapeutic use , COVID-19/complications , COVID-19/physiopathology , COVID-19/virology , Factor V Deficiency/complications , Factor V Deficiency/physiopathology , Factor V Deficiency/virology , Hematologic Tests , Hemorrhage/complications , Hemorrhage/physiopathology , Hemorrhage/virology , Hiccup/complications , Hiccup/physiopathology , Hiccup/virology , Humans , Male , Middle Aged , SARS-CoV-2/growth & development , SARS-CoV-2/pathogenicity , Tomography, X-Ray Computed , Treatment Outcome